2 results match your criteria: "Maine Maternal Opioid Misuse (MaineMOM) Initiative and MaineHealth MaineMOM; Maine Medical Center[Affiliation]"
Experiences of stigma among individuals in recovery from opioid use disorder in a rural setting: A qualitative analysis.
J Subst Abuse Treat
November 2021
Maine Maternal Opioid Misuse Initiative (MaineMOM), MaineHealth Director of Perinatal IMAT, 22 Bramhall Street, Portland, ME 04102, United States.
Introduction: Stigma is a barrier to accessing treatment and support services for individuals with substance use disorder. Stigma is negatively associated with completion of treatment for substance use disorder and management of recovery.
Objective: To learn from individuals in recovery from opioid use disorder in a largely rural area about how their personal experiences of stigma affected their ability to enter into treatment and stay in recovery.
Medication for Addiction Treatment and Postpartum Health Care Utilization Among Pregnant Persons With Opioid Use Disorder.
J Addict Med
March 2022
Muskie School of Public Service, University of Southern Maine, Portland, ME (KAA), Maine Rural Health Research Center, University of Southern Maine, Portland, ME (KAA), Department of Obstetrics and Gynecology, Larner College of Medicine, University of Vermont, Burlington, VT (CAM, MCM), Maine Maternal Opioid Misuse (MaineMOM) Initiative and MaineHealth MaineMOM; Maine Medical Center, Portland, ME (AO'C).
Objective: To estimate treatment and postpartum health care utilization among pregnant persons with opioid use disorder (OUD) in Vermont and Maine.
Methods: Vermont's and Maine's All Payer Claims Databases were used to identify deliveries 2010 to 2018 that were paid for, in part, by Medicaid. OUD was identified among pregnant persons if they had any claim with an OUD-diagnosis code (ICD-9/10) or medication for addiction treatment (MAT) code during the 5 months before delivery event.